Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ABIRATERONA FARMOZ 250 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ABIRATERONA FARMOZ 250 MG COMPRIMIDOS EFG

Approved

STANDARD

ABIRATERONA FARMOZ 250 MG COMPRIMIDOS EFG

Farmoz Sociedade Tecnico Medicinal S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 2, 2024
Approval ID: 4c2524247cbd9ade
Company: Farmoz Sociedade Tecnico Medicinal S.A.
Type: Standard

Approval Details

Approval Id: 4c2524247cbd9ade
Drug Cima Aemps Name: ABIRATERONA FARMOZ 250 MG COMPRIMIDOS EFG
Register Number: 89531
Holder Company Name: Farmoz Sociedade Tecnico Medicinal S.A.
Marketing Company Name: Farmoz Sociedade Tecnico Medicinal S.A.
Authorization Date: 2024-05-02
Dosage Form: COMPRIMIDO
Dose: 250 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Farmoz Sociedade Tecnico Medicinal S.A.

Active Ingredients

ABIRATERONA ACETATO

250 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 2, 2024

Approval ID

4c2524247cbd9ade

Type

Standard

Back to CIMA-AEMPS Approvals